Cofactor Genomics pulls in $18 million with the aim to save lives through RNA research

 Cofactor Genomics has announced an $18 million Series A financing round led by Menlo Ventures, with participation from DCVC, Ascension Ventures, iSelect, Y Combinator, Wilson Sonsini Goodrich & Rosati, and Stanford. The startup, formulated by a team of past Human Genome Project scientists, came out of Y Combinator’s Summer 2015 batch to focus on drug discovery through RNA research.… Read More

Responses are currently closed, but you can trackback from your own site.

Comments are closed.